Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses is a research paper published in Modern Pathology (2020). On theSindex it has a DataRank of 1.3. It has been cited 43 times, with 27 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.568
From this paper's citation signal
Citation Network Contribution
0.751
From 20 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 27 citers.
Cancer Research UK
Grant: 22905
Cancer Research UK
Grant: A22905
NCI NIH HHS
Grant: P50 CA136393
NCI NIH HHS
Grant: R01 CA058598
Cancer Research UK
Grant: A15601
NCI NIH HHS
Grant: U54 CA209978
NCI NIH HHS
Grant: R01 CA122443
NCI NIH HHS
Grant: R01 CA160669
NCI NIH HHS
Grant: U01 CA069417
Cancer Research UK
Grant: C490/A16561
NCI NIH HHS
Grant: R01 CA168758
NCI NIH HHS
Grant: P30 CA015083
NCI NIH HHS
Grant: P30 CA042014
NCI NIH HHS
Grant: R01 CA248288
National Institute for Health Research (NIHR)
Department of Health
FWCI
4.39
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals